Deciding upon these inbound links will acquire you away from KP.org. Kaiser Permanente is not answerable for the content material or insurance policies of exterior Sites. Learn more about connection terms and conditions.
Use or redistribution of any DrugBank written content or data demands a license and suitable citations. Check with product sales for commercial licensing. Make an application for an instructional license.
pentobarbital will decrease the level or impact of nelfinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
fentanyl intranasal and pentobarbital equally improve sedation. Steer clear of or Use Alternate Drug. Restrict use to people for whom alternative treatment method alternatives are inadequate
pentobarbital will lower the level or outcome of rolapitant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Very long-phrase coadministration of sturdy CYP3A4 inducers with rolapitant could appreciably lower rolapitant efficacy.
pentobarbital will lower the extent or influence of cyclosporine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will decrease the level or impact of pantoprazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.
Using barbiturates as sedatives while in the postoperative surgical period of time and as adjuncts to most cancers chemotherapy is effectively set up
pentobarbital will lower the extent or outcome of voriconazole by influencing hepatic enzyme CYP2C9/10 metabolism. Minor/Importance Unfamiliar.
pentobarbital will lessen check here the level or impact of triamcinolone acetonide injectable suspension by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will lower the extent or impact of isavuconazonium sulfate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will lower the extent or effect of methylprednisolone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will minimize the level or outcome of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is a sensitive CYP3A4 substrate. Coadministration with sturdy or average CYP3A4 inducers is contraindicated.
We only use good quality, credible resources to make sure content material accuracy and integrity. You could find out more regarding how we guarantee our content is correct and latest by looking through our editorial policy.